REF
|
NAME (HYPERLINKED)
|
ISSUE DATE
|
|
|
|
| Published guidance |
|
|
| IPG562 |
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules |
Jun-16 |
| IPG499 |
Minimally invasive video-assisted thyroidectomy |
Aug-14 |
| QP case study |
BRAFV600E mutation testing for thyroid cancer: avoiding unnecessary surgery |
Dec-15 |
| IPG255 |
Intraoperative nerve monitoring during thyroid surgery |
Mar-08 |
| IPG130 |
Collagen injection for vocal cord augmentation |
Jun-05 |
| IPG148 |
Retrobulbar irradiation for thyroid eye disease |
Dec-05 |
| ID1059 |
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine |
Aug-18 |
|
|
|
| In development |
|
|
| ID 56 |
Cabozantinib and vandetanib for treating unresectable locally advanced or metastatic medullary thyroid cancer |
Dec-17 |
| ID1059 |
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine |
Dec-18 |
| ID1079 |
Selumetinib for treating differentiated thyroid cancer |
TBC |
|
|
|
| Under consultation |
|
|
| NICE guidelines |
Thyroid disease: assessment and management |
Dec-19 |
|
|
|
| Clinical Knowledge Summaries |
|
|
| Hyperthyroidism |
Scenario: Management : covers the management of people with hyperthyroidism, subclinical hyperthyroidism, and Graves’ orbitopathy. |
Jun-16 |
|
Scenario: Pre-conception, pregnancy, and postpartum : covers the management of pre-conception, pregnant, or postpartum women with hyperthyroidism. |
Jun-16 |
